These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1802 related items for PubMed ID: 12777582

  • 1. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP.
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [Abstract] [Full Text] [Related]

  • 2. Immuno-hematological findings in Delayed Hemolytic Transfusion Reaction (DHTR).
    Thonier V.
    Transfus Clin Biol; 2019 May; 26(2):102-108. PubMed ID: 30885514
    [Abstract] [Full Text] [Related]

  • 3. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions.
    Aygun B, Padmanabhan S, Paley C, Chandrasekaran V.
    Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310
    [Abstract] [Full Text] [Related]

  • 4. Alloimmunization in patients with sickle cell disease and underrecognition of accompanying delayed hemolytic transfusion reactions.
    Coleman S, Westhoff CM, Friedman DF, Chou ST.
    Transfusion; 2019 Jul; 59(7):2282-2291. PubMed ID: 31021439
    [Abstract] [Full Text] [Related]

  • 5. Catastrophic Delayed Hemolytic Transfusion Reaction in a Patient With Sickle Cell Disease Without Alloantibodies: Case Report and Review of Literature.
    Jasinski S, Glasser CL.
    J Pediatr Hematol Oncol; 2019 Nov; 41(8):624-626. PubMed ID: 30179992
    [Abstract] [Full Text] [Related]

  • 6. Anti-N and anti-Doa immunoglobulin G alloantibody-mediated delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease treated with eculizumab and HBOC-201: case report and review of the literature.
    Unnikrishnan A, Pelletier JPR, Bari S, Zumberg M, Shahmohamadi A, Spiess BD, Michael MJ, Harris N, Harrell D, Mandernach MW.
    Transfusion; 2019 Jun; 59(6):1907-1910. PubMed ID: 30768787
    [Abstract] [Full Text] [Related]

  • 7. Anti-Kpa-induced severe delayed hemolytic transfusion reaction.
    Koshy R, Patel B, Harrison JS.
    Immunohematology; 2009 Jun; 25(2):44-7. PubMed ID: 19927619
    [Abstract] [Full Text] [Related]

  • 8. Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes.
    Habibi A, Mekontso-Dessap A, Guillaud C, Michel M, Razazi K, Khellaf M, Chami B, Bachir D, Rieux C, Melica G, Godeau B, Galacteros F, Bartolucci P, Pirenne F.
    Am J Hematol; 2016 Oct; 91(10):989-94. PubMed ID: 27348613
    [Abstract] [Full Text] [Related]

  • 9. Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab.
    Gupta S, Fenves A, Nance ST, Sykes DB, Dzik WS.
    Transfusion; 2015 Mar; 55(3):623-8. PubMed ID: 25257194
    [Abstract] [Full Text] [Related]

  • 10. Delayed hemolytic transfusion reaction presenting as a painful crisis in a patient with sickle cell anemia.
    Fabron A, Moreira G, Bordin JO.
    Sao Paulo Med J; 1999 Jan 07; 117(1):38-9. PubMed ID: 10413970
    [Abstract] [Full Text] [Related]

  • 11. Severe neurologic complication after delayed hemolytic transfusion reaction in 2 children with sickle cell anemia: significant diagnosis and therapeutic challenges.
    Elenga N, Mialou V, Kebaïli K, Galambrun C, Bertrand Y, Pondarre C.
    J Pediatr Hematol Oncol; 2008 Dec 07; 30(12):928-30. PubMed ID: 19131783
    [Abstract] [Full Text] [Related]

  • 12. A diagnostic nomogram for delayed hemolytic transfusion reaction in sickle cell disease.
    Mekontso Dessap A, Pirenne F, Razazi K, Moutereau S, Abid S, Brun-Buisson C, Maitre B, Michel M, Galacteros F, Bartolucci P, Habibi A.
    Am J Hematol; 2016 Dec 07; 91(12):1181-1184. PubMed ID: 27538126
    [Abstract] [Full Text] [Related]

  • 13. Extended phenotyping does not preclude the occurrence of delayed haemolytic transfusion reactions in sickle cell disease.
    Gerritsma J, Bongaerts V, Eckhardt C, Heijboer H, Nur E, Biemond B, van der Schoot E, Fijnvandraat K, SCORE consortium.
    Br J Haematol; 2022 Feb 07; 196(3):769-776. PubMed ID: 34632580
    [Abstract] [Full Text] [Related]

  • 14. Clinical presentation of delayed hemolytic transfusion reactions and hyperhemolysis in sickle cell disease.
    Fasano RM, Miller MJ, Chonat S, Stowell SR.
    Transfus Clin Biol; 2019 May 07; 26(2):94-98. PubMed ID: 30837199
    [Abstract] [Full Text] [Related]

  • 15. Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma-to-red blood cell exchange transfusion.
    Uhlmann EJ, Shenoy S, Goodnough LT.
    Transfusion; 2014 Feb 07; 54(2):384-8. PubMed ID: 23692505
    [Abstract] [Full Text] [Related]

  • 16. Delayed hemolytic transfusion reaction in children with sickle cell disease.
    de Montalembert M, Dumont MD, Heilbronner C, Brousse V, Charrara O, Pellegrino B, Piguet C, Soussan V, Noizat-Pirenne F.
    Haematologica; 2011 Jun 07; 96(6):801-7. PubMed ID: 21330322
    [Abstract] [Full Text] [Related]

  • 17. Transfusion of multiple units of Js(b+) red blood cells in the presence of anti-Jsb in a patient with sickle beta-thalassemia disease and a review of the literature.
    Yuan S, Ewing NP, Bailey D, Salvador M, Wang S.
    Immunohematology; 2007 Jun 07; 23(2):75-80. PubMed ID: 18004938
    [Abstract] [Full Text] [Related]

  • 18. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV, Steane E, Cunningham G, Frenkel EP.
    Arch Intern Med; 1988 Nov 07; 148(11):2485-9. PubMed ID: 3142382
    [Abstract] [Full Text] [Related]

  • 19. Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death.
    Chadebech P, Habibi A, Nzouakou R, Bachir D, Meunier-Costes N, Bonin P, Rodet M, Chami B, Galacteros F, Bierling P, Noizat-Pirenne F.
    Transfusion; 2009 Sep 07; 49(9):1785-92. PubMed ID: 19413729
    [Abstract] [Full Text] [Related]

  • 20. Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience.
    Vidler JB, Gardner K, Amenyah K, Mijovic A, Thein SL.
    Br J Haematol; 2015 Jun 07; 169(5):746-53. PubMed ID: 25753472
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 91.